Web8 Feb 2024 · Highline Sciences Highline Sciences is a consulting and CRO firm that offers Oncology treatment services. Acquiring Organization: Tempus Tempus is a technology … Web1 Sep 2024 · The Tempus xF assay is a non-invasive, liquid biopsy panel designed to provide clinical decision support for solid tumors. It detects genomic alterations circulating in patients' peripheral blood, including single nucleotide variants (SNVs)/insertions and deletions (indels) in 105 genes, copy number gains (CNGs) in 6 genes, copy number …
Highline Sciences Acquired by Tempus - KO
WebAll departments Bioinformatics Data Science Data Science - Biostatistics Data Science - Knowledge Technologies Engineering External Affairs Finance & Accounting G&A Highline Sciences, An Oncology Clinical Research Organization IT & Enterprise Internships Laboratory (Atlanta) Laboratory (Chicago) Laboratory (Raleigh-Durham) Marketing Medical Science … Web9 Feb 2024 · February 9, 2024 Tempus, a precision medicine solutions company led by Groupon co-founder Eric Lefkofsky, has snagged Highline Sciences to expand its capabilities into complex clinical research. San Francisco-based Highline is a specialized, full-service clinical contract research organization (CRO) focused on oncology. disney sydney office
Colin Rothwell posted on LinkedIn
Web8 Feb 2024 · CHICAGO, February 08, 2024 -- ( BUSINESS WIRE )--Tempus, a leader in artificial intelligence and precision medicine, today announced the acquisition of Highline Sciences, a specialized,... Web8 Feb 2024 · Tempus, a leader in artificial intelligence and precision medicine, today announced the acquisition of Highline Sciences, a specialized, full-service clinical contract research organization (CRO) focused on oncology. Highline Sciences manages and executes on early and late-stage clinical trials, applying a customized approach to each … WebSeries G - Tempus . $200M: Nov 1, 2024: Jonathan Ozeran . Venture Round - Tribe XR ... Highline Sciences acquired by Tempus ... disney sxsw robot